• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨苯蝶啶在大鼠体内的分布及药代动力学

Distribution and pharmacokinetics of triamterene in rats.

作者信息

Kau S T, Sastry B V

出版信息

J Pharm Sci. 1977 Jan;66(1):53-6. doi: 10.1002/jps.2600660112.

DOI:10.1002/jps.2600660112
PMID:833742
Abstract

The tissue distribution of 14C-triamterene was examined in the fact. After intravenous administration of 14C-triamterene, high concentration ratios between tissues and blood were found in most tissues except the brain, fat, and testes. The maximal concentration of the drug was in the kidneys, liver, heart, lungs, and skeletal muscle within the first 20 min, when the maximal natriuresis was observed. No metabolite of triamterene was detected in these tissues. The pharmacokinetics of 14C-triamterene also were investigated. The volume of distribution of the drug was greater in the central compartment (60% of the dose) than in the peripheral compartment (40%). The binding of the drug to skeletal muscle is responsible for the fraction of the dose in the peripheral compartment. Rate constants indicate that slow elimination of triamterene is related to its binding to tissue in the central compartment.

摘要

在实验中检测了14C-氨苯蝶啶的组织分布。静脉注射14C-氨苯蝶啶后,除脑、脂肪和睾丸外,大多数组织中组织与血液之间的浓度比很高。给药后最初20分钟内,药物在肾脏、肝脏、心脏、肺和骨骼肌中的浓度最高,此时观察到最大利钠作用。在这些组织中未检测到氨苯蝶啶的代谢产物。还研究了14C-氨苯蝶啶的药代动力学。药物在中央室的分布容积(占剂量的60%)大于外周室(占剂量的40%)。药物与骨骼肌的结合导致了外周室中药物剂量的一部分。速率常数表明,氨苯蝶啶的缓慢消除与其在中央室中与组织的结合有关。

相似文献

1
Distribution and pharmacokinetics of triamterene in rats.氨苯蝶啶在大鼠体内的分布及药代动力学
J Pharm Sci. 1977 Jan;66(1):53-6. doi: 10.1002/jps.2600660112.
2
Pharmacokinetics of triamterene and its metabolite in man.氨苯蝶啶及其代谢物在人体中的药代动力学。
J Pharmacokinet Biopharm. 1982 Oct;10(5):507-23. doi: 10.1007/BF01059034.
3
[Distribution volume and elimination of triamterene and its active metabolites in the rabbit (author's transl)].
Arzneimittelforschung. 1978;28(8):1414-6.
4
Triamterene kinetics and dynamics in cirrhosis.氨苯蝶啶在肝硬化中的动力学和动态变化
Clin Pharmacol Ther. 1984 Jun;35(6):831-7. doi: 10.1038/clpt.1984.121.
5
[Age dependence of the pharmacokinetics of triamterene].[氨苯蝶啶药代动力学的年龄依赖性]
Acta Biol Med Ger. 1973;30(1):121-32.
6
Pharmacokinetics of triamterene after i.v. administration to man: determination of bioavailability.氨苯蝶啶静脉注射给人体后的药代动力学:生物利用度的测定。
Eur J Clin Pharmacol. 1983;25(2):237-41. doi: 10.1007/BF00543797.
7
Metabolism of triamterene in the rat.
Drug Metab Dispos. 1975 Sep-Oct;3(5):345-51.
8
[Pharmacokinetics of triamterene and its active metabolites in renal insufficiency (author's transl)].氨苯蝶啶及其活性代谢产物在肾功能不全患者中的药代动力学(作者译)
Arzneimittelforschung. 1978;28(8):1420-5.
9
Pharmacokinetics of triamterene.
Clin Exp Hypertens A. 1983;5(2):249-69. doi: 10.3109/10641968309048825.
10
Pharmacokinetics of a fixed combination with propranolol, hydrochlorothiazide and triamterene.
Arzneimittelforschung. 1979;29(11):1746-52.